our Partnerships and Branded Content Editor Rory Halperin says this Waterpik toothbrush might be just what you’re looking for. “I really liked that it's a 2-in-1 toothbrush and flosser ...

As the Strategist’s personal-hygiene writer, I find brushing my teeth is much more enjoyable with an electric toothbrush. Plus, it’s nice knowing I’m always getting a thorough brush thanks ...

Waterpik Sonic-Fusion 2.0 Professional Flossing Toothbrush Waterpik Sonic-Fusion 2.0 Professional Flossing Toothbrush $ at Amazon Waterpik Sonic-Fusion 2.0 Professional Flossing Toothbrush $ at ...

Purdue will offer the most innovative approach to learning through a deep investment in experiential learning, advanced technologies, flexible degree options, integrated student life experiences and a ...

Adrian Kingsley-Hughes is an internationally published technology author who has devoted over two decades to helping users get the most from technology -- whether that be by learning to program ...

AstraZeneca (AZN) said it would acquire Canadian clinical-stage oncology company Fusion Pharmaceuticals (FUSN) for up to about $2.4 billion ... AstraZeneca edged down 0.6%. Fusion focuses on ...

Fusion Pharmaceuticals Inc. (FUSN) closed the most recent trading day at $21.24, moving -0.09% from the previous trading session. This change was narrower than the S&P 500's daily loss of 0.58%.

Sonic Automotive (NYSE:SAH) declares $0.30/share quarterly dividend, in line with previous. Forward yield 2.35% Payable July 15; for shareholders of record June 14; ex-div June 14. See SAH ...

What is the price of platinum today? The price of platinum opened at $967.85 per ounce, as of 9 a.m. That’s down 0.69% from the previous day and down 2.01% from the beginning of the year.

There’s no telling what visionOS 1.2 will bring–Spatial Personas has already come to all Vision Pro headsets before the 1.2 release. We don’t know yet what is new in visionOS 1.2 ...

Fusion Pharmaceuticals Inc., a clinical-stage ... The company’s lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and ...